1. Modern Strategies for Basal Insulin Use in T2D

3. Progressive Nature of T2D

4. Clinical Recommendations for Use of Basal Insulin in T2D

5. Addressing the Misperceptions of Insulin

6. Action Profile of Newer Basal Insulins

7. Reduced Hypoglycemia With Glargine U300 vs Glargine U100

8. SWITCH 1 Study Glargine U100 vs Degludec in T1D

9. SWITCH 2 Study Glargine U100 vs Degludec in T2D

10. Patient Case: Shawn

11. Treatment Intensification

12. A Practical Insulin Titration Scheme

13. Reducing Risk of Hypoglycemia

14. Patient Case (cont)

17. Fixed-Dose Combination Products in Development

18. Concluding Remarks

19. Abbreviations